BBOT – bridgebio oncology therapeutics, inc. (US:NASDAQ)

News

BBOT to Participate in Upcoming Investor Healthcare Conferences
BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
BridgeBio Oncology Therapeutics (NASDAQ:BBOT) was given a new $23.00 price target on by analysts at Stifel Nicolaus.
Biotech investor Cormorant secures $150M for another SPAC deal [Yahoo! Finance]
Helix Acquisition prices $150M initial public offering [Seeking Alpha]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com